World HLA-B51 prevalences among healthy control subjects: comparison between Africa (low prevalence of HLA-B51 in controls and low prevalence of Behçet’s disease) and Middle East, Asia, and Far East (high prevalence of HLA-B51 and high prevalence of Behçet’s disease)
| Region | Country | Population or area | HLA-B51 (%) |
|---|---|---|---|
| Africa | Algeria | 4.7 | |
| Burkino Faso | Rimaibe | 6 | |
| Equatorial | Bubi | 1.9 | |
| Libya | Jewish | 8.7 | |
| Nigeria | West | 2.6 | |
| Gambia | Mandinka | 2.4 | |
| Sudan | Noba | 2.2 | |
| Sudan | Shiegia | 23 | |
| Zaire | 4.1 | ||
| Zimbabwe | 0.5 | ||
| Middle East | Georgia | Georgians | 13.7 |
| Georgia | Kurdish | 16.2 | |
| Iraq | Jewish | 2.3 | |
| Lebanon | 6.1 | ||
| Palestine | 15.3 | ||
| Asia (cont) | China | North | 2.5 |
| China | Han (South) | 6.2 | |
| Thailand | Central | 7.7 | |
| Tibet | 13.4 | ||
| Vietnam | 1.8 | ||
| China | Man (North East) | 7.3 | |
| China | Uygur (West) | 8.8 | |
| India | Punjabi | 0 | |
| India | North | 7.6 | |
| India | Iyers (South) | 9.5 | |
| India | North Delhi | 13 | |
| Japan | Mid | 18 | |
| Japan | South | 22.3 | |
| Korea | 13 | ||
| Saudi Arabia | 26 | ||
| Turkey | 24 |